| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2021―Jun―21 |
The corona virus SARS-CoV-2 and the pandemic Covid19 |
Pascale Cossart |
| 2 |
[GO] |
2021―Jun―21 |
Structure-function relations of the SARS-CoV-2 spike protein and impact of mutations in the variants of concern |
Félix Rey |
| 3 |
[GO] |
2021―Mar―04 |
COVID-19: individual and herd immunity |
Jean-François Bach, Patrick Berche, Lucienne Chatenoud, Dominique Costagliola, Alain-Jacques Valleron |
| 4 |
[GO] |
2021―Feb―24 |
COVID-19 and drugs: pathophysiology and therapeutic approaches |
Patrick Couvreur, Daniel Louvard |
| 5 |
[GO] |
2021―Feb―09 |
Insufficient type I IFN immunity underlies life-threatening COVID-19 pneumonia |
Paul Bastard, Qian Zhang, Aurélie Cobat, Emmanuelle Jouanguy, Shen-Ying Zhang, Laurent Abel, Jean-Laurent Casanova |
| 6 |
[GO] |
2021―Jan―12 |
SARS-CoV-2 vaccines, where do we stand? |
Alain Fischer |
| 7 |
[GO] |
2020―Nov―24 |
Origin, evolution and global spread of SARS-CoV-2 |
Anna Zhukova, Luc Blassel, Frédéric Lemoine, Marie Morel, Jakub Voznica, Olivier Gascuel |
| 8 |
[GO] |
2020―Oct―12 |
Leçons biochimiques et statistiques de l’évolution du virus SARS-CoV-2 : nouveaux chemins pour combattre les virus |
Nicolas Cluzel, Amaury Lambert, Yvon Maday, Gabriel Turinici, Antoine Danchin |
| 9 |
[GO] |
2020―Apr―24 |
A nicotinic hypothesis for Covid-19 with preventive and therapeutic implications |
Jean-Pierre Changeux |
